Register to chat with like-minded investors on our interactive forums.

Get Started

VSTM

Verastem (VSTM)

Verastem Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:VSTM

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 Next >>

Date	Time	Source	Headline	Symbol	Company
05/09/2023	4:19PM	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:VSTM	Verastem Inc
05/09/2023	4:05PM	Business Wire	Verastem Oncology Reports First Quarter 2023 Financial Results and Highlights Recent Company Progress	NASDAQ:VSTM	Verastem Inc
05/01/2023	7:00AM	Business Wire	Verastem Oncology to Participate in Upcoming Investor Conferences	NASDAQ:VSTM	Verastem Inc
04/26/2023	4:05PM	Business Wire	New Data from Interim Analysis of Verastem Oncology’s RAMP 201 Trial Evaluating Avutometinib and Defactinib in Recurrent Low-Grade Serous Ovarian Cancer to be Presented at the American Society of Clinical Oncology Annual Meeting	NASDAQ:VSTM	Verastem Inc
04/25/2023	6:06AM	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:VSTM	Verastem Inc
04/24/2023	4:11PM	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:VSTM	Verastem Inc
04/18/2023	7:05AM	Business Wire	Verastem Oncology to Present at the Stifel 2023 Virtual Targeted Oncology Days	NASDAQ:VSTM	Verastem Inc
04/06/2023	4:31PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VSTM	Verastem Inc
04/06/2023	4:05PM	Business Wire	Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:VSTM	Verastem Inc
04/05/2023	4:13PM	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:VSTM	Verastem Inc
03/28/2023	4:32PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VSTM	Verastem Inc
03/27/2023	4:31PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VSTM	Verastem Inc
03/20/2023	4:58PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VSTM	Verastem Inc
03/15/2023	7:00AM	Business Wire	New Verastem Oncology Initiative, Let’s Talk About LGSOC, Calls Attention to Rare Form of Ovarian Cancer	NASDAQ:VSTM	Verastem Inc
03/14/2023	5:01PM	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:VSTM	Verastem Inc
03/14/2023	4:05PM	Business Wire	Verastem Oncology Reports Fourth Quarter and Full Year 2022 Financial Results and Highlights Recent Company Progress	NASDAQ:VSTM	Verastem Inc
02/14/2023	4:02PM	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:VSTM	Verastem Inc
02/02/2023	7:01AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VSTM	Verastem Inc
02/02/2023	7:00AM	Business Wire	Verastem Oncology Outlines Key 2023 Strategic Priorities and Upcoming Catalysts for Advancing Avutometinib as a Backbone of Therapy for RAS Pathway-Driven Cancers	NASDAQ:VSTM	Verastem Inc
01/31/2023	4:07PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VSTM	Verastem Inc
01/31/2023	4:07PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VSTM	Verastem Inc
01/25/2023	8:19AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VSTM	Verastem Inc
01/24/2023	5:46PM	Business Wire	Verastem Oncology Announces Up to $60 Million Private Placement Offering of Series B Convertible Preferred Stock	NASDAQ:VSTM	Verastem Inc
01/24/2023	5:45PM	Business Wire	Verastem Oncology Announces Positive Data and Regulatory Update from Planned Interim Analysis of Registration-Directed Phase 2 RAMP-201 Trial of Avutometinib and Defactinib in Recurrent Low-Grade Serous Ovarian Cancer	NASDAQ:VSTM	Verastem Inc
01/24/2023	5:30PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VSTM	Verastem Inc
01/18/2023	4:05PM	Business Wire	Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:VSTM	Verastem Inc
01/09/2023	4:07PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VSTM	Verastem Inc
12/29/2022	4:08PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VSTM	Verastem Inc
12/20/2022	4:11PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VSTM	Verastem Inc
12/20/2022	4:11PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VSTM	Verastem Inc

Showing the most relevant articles for your search:NASDAQ:VSTM

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 Next >>

Globestar Therapeutics (PK)

Emergent Health (PK)

Golden Triangle Ventures (PK)

Kraig Biocraft Laborator... (QB)

Therapeutic Solutions (PK)

Elite Pharmaceuticals (QB)

Virexit Technologies (PK)

Cann American (CE)

Code Green Apparel (PK)

TPT Global Tech (PK)

RespireRx Pharmaceuticals (PK)

SMC Entertainment (PK)

Bioelectronics (PK)

Delayed Upgrade Clock